The pegfilgrastim injection market is projected to grow from USD 3.7 billion in 2025 to USD 6.8 billion by 2035, at a CAGR of 6.3%. Innovative Drugs will dominate with a 64.0% market share, while neoplastic diseases will lead the therapeutic application segment with a 78.0% share.